基于行政数据的医院衰弱风险评分与卒中结局的关联
结果显示衰弱评分每增加1分与住院时间延长、90天死亡、再入院及健康相关生活质量更差相关,且对30天死亡的预测精度与Charlson和Elixhauser指数相当。
要点
- 衰弱评分每增1分,90天死亡风险增加4%(调整HR 1.04)。
- 衰弱评分每增1分,住院时间延长风险增加5%(调整OR 1.05)。
- 衰弱评分对30天死亡的预测精度与Charlson和Elixhauser指数相当。
核心结论
- 衰弱程度越高,卒中/短暂性脑缺血发作后结局越差。
- 衰弱评分在风险调整结局评估中的精度与Charlson和Elixhauser指数相当。
研究设计与样本
- 使用ICD-10编码以5年回顾期计算医院衰弱风险评分,并分为无风险(0)、低风险(1–5)、中风险(5–15)和高风险(>15)四组。
- 采用多水平模型评估衰弱评分与结局的关联,并比较其与Charlson和Elixhauser指数对30天死亡的预测性能。
主要发现
- 15%的患者在90天内死亡;衰弱评分分布为无风险9%、低风险23%、中风险45%、高风险22%。
- 衰弱评分每增加1分(连续变量)与住院时间延长(调整OR 1.05,95%CI 1.04–1.06)、90天死亡(调整HR 1.04,95%CI 1.03–1.05)、再入院(调整OR 1.02,95%CI 1.02–1.03)及健康相关生活质量更差(中位差 −0.010,95%CI −0.012至−0.010)相关。
- 调整衰弱评分后对30天死亡的解释略优于其他指数(如C统计量更大)。
关键数值与推荐
- 衰弱评分分组:无风险(0分)、低风险(1–5分)、中风险(5–15分)、高风险(>15分)。
- 衰弱评分每增加1分对应的调整效应:住院时间延长OR 1.05(95%CI 1.04–1.06)、90天死亡HR 1.04(95%CI 1.03–1.05)、再入院OR 1.02(95%CI 1.02–1.03)、健康相关生活质量中位差 −0.010(95%CI −0.012至−0.010)。
临床怎么用
- 可利用行政数据计算的衰弱评分识别卒中后高风险患者,辅助风险分层。
- 衰弱评分可用于风险调整结局比较,其精度与Charlson和Elixhauser指数相当。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Conditions associated with frailty are common in people experiencing stroke and may explain differences in outcomes. We assessed associations between a published, generic frailty risk score, derived from administrative data, and patient outcomes following stroke/transient ischemic attack; and its accuracy for stroke in predicting mortality compared with other measures of clinical status using coded data. METHODS: Patient-level data from the Australian Stroke Clinical Registry (2009–2013) were linked with hospital admissions data. We used International Statistical Classification of Diseases and Related Health Problems, Tenth Revision codes with a 5-year look-back period to calculate the Hospital Frailty Risk Score (termed Frailty Score hereafter) and summarized results into 4 groups: no-risk (0), low-risk (1–5), intermediate-risk (5–15), and high-risk (>15). Multilevel models, accounting for hospital clustering, were used to assess associations between the Frailty Score and outcomes, including mortality (Cox regression) and readmissions up to 90 days, prolonged acute length of stay (>20 days; logistic regression), and health-related quality of life at 90 to 180 days (quantile regression). The performance of the Frailty Score was then compared with the Charlson and Elixhauser Indices using multiple tests (eg, C statistics) for predicting 30-day mortality. Models were adjusted for covariates including sociodemographics and stroke-related factors. RESULTS: Among 15 468 adult patients, 15% died ≤90 days. The frailty scores were 9% no risk; 23% low, 45% intermediate, and 22% high. A 1-point increase in frailty (continuous variable) was associated with greater length of stay (ORadjusted, 1.05 [95% CI, 1.04 to 1.06), 90-day mortality (HRadjusted, 1.04 [95% CI, 1.03 to 1.05]), readmissions (ORadjusted, 1.02 [95% CI, 1.02 to 1.03]; and worse health-related quality of life (median difference, −0.010 [95% CI −0.012 to −0.010]). Adjusting for the Frailty Score provided a slightly better explanation of 30-day mortality (eg, larger C statistics) compared with other indices. CONCLUSIONS: Greater frailty was associated with worse outcomes following stroke/transient ischemic attack. The Frailty Score provides equivalent precision compared with the Charlson and Elixhauser indices for assessing risk-adjusted outcomes following stroke/transient ischemic attack.
引用
- Kilkenny MF, Phan HT, Lindley RI, et al. Utility of the Hospital Frailty Risk Score Derived From Administrative Data and the Association With Stroke Outcomes. Stroke. 2021. PMID: 34134509. doi:10.1161/STROKEAHA.120.033648
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。